Business
December 5, 2017; Cell MedX Corp. Appoints Dr. Terrance Owen as CEO and Director
December 5, 2017; Cell MedX Corp. Appoints Dr. Terrance Owen as CEO and Director.
About this update from Stimcell Energetics Inc.
[{"type":"text","content":"Carson City, Nevada, December 5, 2017, Cell MedX Corp. (OTCQB: CMXC), (“Cell MedX” or the “Company”), an early development stage bio-tech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, is pleased to announce that it has appointed Dr. Terrance Owen to the Board of Directors and as Chief Executive Officer. Dr. Owen replaces Mr. McEnulty, as CEO of the Company. Mr. McEnulty will continue to serve on the board of directors.On December 1, 2017, the Company entered into a management consulting agreement (the “Agreement”) with Dr. Owen. Under the terms of the Agreement, Dr. Owen will act as the Company’s Chief Executive Officer for the term of one year, expiring on November 30, 2018, renewing automatically for consecutive 1-year terms, and will be entitled to a consulting fee of CAD$16,666 per month.Dr. Owen obtained a BSc (Honours) in Biology from the University of Victoria, an MSc in Biology from the University of New Brunswick, a PhD in Zoology from the University of British Columbia, and a MBA from Simon Fraser University.From December 1980 to April 2002 Dr. Owen was the President and a director of Helix Biotech, a laboratory providing DNA identity testing services for paternity, immigration, and forensic cases. From July 1995 to June 1998 Dr. Owen was the President, a director, and a co-founder of Helix BioPharma Corp, listed on the TSX Venture Exchange (TSX:HBP), a generic pharmaceutical company. From 2000 to 2013, Dr. Owen was the President, CEO, director, and co-founder of ALDA Pharmaceuticals Corp., an infection control company now named Vanc Pharmaceuticals Inc. (TSX-V:VANC). Dr. Owen was also a co-founder of Champion Pain Care Corporation (OTCQB:CPAI) and was appointed as its CEO from October 2013 to June 2015, as a Director from October 2013 to February 2017, and as CFO from March 2015 to February 2017.Dr. Owen commented; “I am very pleased to become part of the Cell MedX team. The technology has a number of important applications and great potential to help many people who are seeking relief from their health problems. The team has made tremendous progress and I am committed to maintaining that momentum.”Mr. McEnulty, director and former CEO of the Company, stated, “We are very exited to welcome Dr. Owen to the Cell MedX’...